Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650

MLA

Boris Mizaikoff, et al. “Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650.” Pharmaceutics, Jan. 2019. EBSCOhost, https://doi.org/10.3390/pharmaceutics11080367.

APA

Boris Mizaikoff, Harald Luksch, Katharina Schindowski, Johannes Flamm, Patrick Schlossbauer, & Simone Ladel. (2019). Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650. Pharmaceutics. https://doi.org/10.3390/pharmaceutics11080367

Chicago

Boris Mizaikoff, Harald Luksch, Katharina Schindowski, Johannes Flamm, Patrick Schlossbauer, and Simone Ladel. 2019. “Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650.” Pharmaceutics, January. doi:10.3390/pharmaceutics11080367.